The PMP Strategy for Maximizing Profit in Your Practice: Plan, Monitor, and Push
How to thrive in today’s increasingly competitive hearing healthcare business.
Read MoreDec 13, 2018 | Growth Strategies, Practice Building, Practice Management, Staffing & Training | 0 |
How to thrive in today’s increasingly competitive hearing healthcare business.
Read MoreDec 13, 2018 | Patient Care | 0 |
To maintain consumer safety while dispensing hearing aids and other hearing amplification devices when licensed providers are not involved, a multidisciplinary research team developed the Consumer Ear Disease Risk Assessment (CEDRA) questionnaire, which is designed to identify the risk of diseases with ear and hearing symptoms.
Read MoreDec 10, 2018 | Hearing Aids, Industry News | 0 |
The opening of the Sac Clinic, dba Value Audiology & Hearing Aid Center, is part of InnerScope’s 6-12 month Northern California Audiological Clinic Expansion Plan.
Read MoreNov 28, 2018 | Cochlear Implants, Components, Evaluation, Events, In the Ear, Industry News, Over the Counter, Regulation, Speech in Noise? | 1 |
The FDA has announced it will be modernizing its 510(k) clearance pathway, which accounts for the majority of devices that the Agency reviews, in what it characterizes as a “generational change.” Specifically, the Agency says it will concentrate on more recent predicates and technological advances in its future decision-making process, and ramp up its post-market surveillance of products.
Read MoreTo maintain consumer safety while dispensing hearing aids and other amplification devices when licensed providers are not involved, a multidisciplinary research team developed the Consumer Ear Disease Risk Assessment (CEDRA) questionnaire, which is designed to identify the risk of diseases with ear and hearing symptoms. Noted researcher Donald Nielsen, PhD, explains its development and how the self-administered test can be used online for free.
Read MoreNov 14, 2018 | Hearing Aids, Industry News, Marketing, Military & Industrial, Surveys & Statistics | 1 |
According to HIA statistics, the US hearing aid market has experienced sales gains of 5.9% and may exceed 4 million hearing aid units dispensed by the end of 2018. Here’s a summary of the US hearing industry statistics through the third quarter of this year, including a look at the most-common styles of hearing aids sold.
Read MoreNov 9, 2018 | Components, In the Ear, Industry News | 0 |
For the 2018 third quarter, the company reported net sales of $30.1 million, up 20.2% from $25.1 million in the prior-year period. According to the announcement, the increase was primarily due to year-over-year revenue gains from IntriCon’s largest medical customer and growth in its value-based hearing healthcare business.
Read MoreNov 5, 2018 | Patient Fittings | 0 |
On October 5, the FDA granted De Novo status to Bose Corporation for a self-fitting hearing aid for mild-to-moderate hearing loss.
Read MoreNov 1, 2018 | Office Management Systems, People, Prevention, Research | 0 |
Shennib brings over 30 years of experience in healthcare innovations, starting his career in implantable cardiac pacing, and later taking leading roles with several hearing aid manufacturers including ReSound and InSound Medical, where he invented and developed the Lyric™ hearing device.
Read MoreOct 31, 2018 | Cochlear Implants, Events, Marketing, Over the Counter, Regulation | 0 |
The 2018 Academy of Doctors of Audiology (ADA) Convention had the theme, “Bolder than Ever,” and lived up to it with 3 days of excellent seminars and events in Orlando, Fla, on October 22-24.
Read MoreOct 26, 2018 | Behind the Ear, Hearing Aids, Hearing Products, In the Ear, Marketing, Over the Counter | 1 |
The Zounds product portfolio featured on Walmart.com includes the Vizara, a 16-Channel digital rechargeable hearing system; the Prezia, a 16-Channel premium digital hearing aid, and the Hearing in a Box digital RIC hearing aid.
Read MoreOct 23, 2018 | Over the Counter, Research | 0 |
Before jumping to the conclusion that any PSAP and/or future OTC hearing device would be suitable for the many different types of hearing losses, we need to look at their coupler and real-ear performance data. This study by Adam Voss, Kristi Oeding, AU Bankaitis, John Pumford, and Michael Valente suggests current PSAPs are suitable for mild losses only.
Read MoreOct 21, 2018 | Patient Fittings | 2 |
The FDA has concluded that the Bose Hearing Aid should be classified as a Class II device under the generic name “self-fitting air-conduction hearing aid,” according to an October 5 letter from the Agency. Accordingly, Bose is free to market the device immediately subject to general provisions and special controls required by FDA. Subsequent applications for a self-fitting hearing aid will need to undergo premarket notification requirements, according to the Agency.
Read MoreOct 11, 2018 | Industry News, Over the Counter | 1 |
Shares of three large hearing aid companies—GN Store Nord A/S, William Demant Holding A/S, and Sonova Holding AG—dropped significantly on Monday, according to an article on ‘Bloomberg.’
Read MoreOct 11, 2018 | Uncategorized | 1 |
Shares of three large hearing aid companies—GN Store Nord A/S, William Demant Holding A/S, and Sonova Holding AG—dropped significantly on Monday, according to an article on ‘Bloomberg.’
Read More